EnvIRONmental Aspects in Myelodysplastic Syndrome

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Systemic iron overload is a common complication in myelodysplastic syndromes (MDS), stemming from ineffective erythropoiesis and red blood cell transfusions.
• Iron homeostasis and its impact vary across MDS subtypes, necessitating personalized assessment.
• Both iron and reactive oxygen species (ROS) are essential in low amounts but detrimental in excess, particularly within the bone marrow niche.

Purpose of the Study:

• To review the multifaceted roles of iron and ROS in MDS pathophysiology.
• To explore the implications of iron overload and ROS on hematopoiesis and clonal evolution in MDS.
• To examine hepcidin regulation and its interplay with erythropoiesis and inflammation in MDS.

Main Methods:

• Literature review focusing on iron overload, ROS, hematopoiesis, and clonal evolution in MDS.
• Analysis of hepcidin regulation and its interaction with erythropoiesis and inflammation.
• Discussion of genetic alterations, exemplified by TET2 mutations, and their impact on iron homeostasis and hematopoiesis.

Main Results:

• Iron overload and ROS significantly affect the bone marrow niche, impacting hematopoiesis and potentially contributing to clonal evolution in MDS.
• Hepcidin regulation in MDS is complex, influenced by erythropoiesis and inflammatory signals.
• Genetic mutations, such as TET2, disrupt iron homeostasis and hematopoiesis, indicating subtype-specific implications.

Conclusions:

• Iron and ROS dysregulation is a critical factor in MDS progression and warrants further investigation.
• Understanding the diverse genetic landscape and its effect on iron metabolism is essential for effective MDS treatment strategies.
• Comprehensive patient workup is needed to tailor therapies for iron overload and associated complications in MDS.